ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
China-Based Ivy Capital Invests in Betagenon's Clinical Stage AMPK Activator Program
January 20, 2020Balticgruppen Bio, the Umea based Biotech company focused on development of AMPK activator compounds, operating under the trademark Betagenon, has closed a funding round with China based asset management firm Ivy Capital granting the company 3 MUSD of fun
Pharma Sources Insight January 2025
